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Since birth of the first “test tube” baby—Louise Brown—
in 1978, pioneered by physiologist Robert G. Edwards and
surgeon Patrick C. Steptoe, there was a great advance in
reproductive biomedicine made by amazing people, who
insisted on this path in spite of pressure from society. In
vitro fertilization procedure indeed became an established
way to treat couples with severe infertility problems, and
until today more than four million babies have been born
worldwide in this way. The field of assisted conception is a
fast-developing domain at both the basic and clinical level.
This is reflected in the 31 papers in this special issue, spanning
a wide range of topics including female and male infertility,
gametes, embryos, pregnancy, and babies born after assisted
conception.
There are some new aspects to study and think about
female (in)fertility. The methodology of proteomics was
exposed to be important in potential linking oxidative stress
and female infertility (S. Gupta et al.). One of the main
tasks in the in vitro fertilization program remains to better
elucidate oocyte quality. This can be facilitated by novel
proteomic and secretome tools as have been used in animal
models, although some obstacles still need to be resolved
before these can be applied to human cells (I. Virant-Klun and
J. Krijgsveld). The quality of oocytes also depends on mutual
interactions with surrounding granulosa cells; therefore,
global profiling of gene expression of follicular cumulus cells
using microarrays and next generation sequencing (NGS)
may lead to establishment of new reliable biomarkers to
select oocytes with the highest developmental potential (E.
Chronowska). Oocyte maturity is a prerequisite for suc-
cessful fertilization and pregnancy. Time-lapse dynamics of
oocyte chromatin organisation during meiotic resumption
was observed in a mouse model, providing a pathway of
transition from the GV to the MII stage oocyte (M. Belli et
al.). In vitro maturation (IVM) of human oocytes is still a
suboptimal procedure resulting in impaired oocyte develop-
mental potential. However, results on bovine oocytes showed
that addition of hyaluronan (HA) to the IVM medium
improved the quality of in vitro derived embryos-blastocysts,
which expressed less DNA fragmentation (J. Opiela et al.).
Oocyte quality can be influenced by female infertility factors.
In nonoverweight women with polycystic ovary syndrome
(PCOS), the association between follicular fluid leptin and
serum insulin was confirmed (G. Garruti et al.). It was
proposed that lower levels of leptin in follicular fluid may
explain the lower oocyte quality and fertilization in these
women and this may be related to the level of insulin and/or
insulin resistance.
Most instances of severe infertility in men cannot be
explained. A special concern is represented by male and
couple fertility impairment due to human papilloma virus
(HPV)DNA sperm infection (S. Gizzo et al.).The question of
potential negative impact of HPV infection on semen quality
is still open, despite high prevalence of infection (37.1%) in
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men from infertile couples (B.Golob et al.). In nonobstructive
azoospermia, the increase in volume density of both the CD
68-positive macrophages and vacuolated Leydig cells and a
positive correlation between the volume densities of these cell
types were observed; it was proposed that overstimulation
of Leydig cells, together with a negative paracrine action of
macrophages, could result in the damage of steroidogenesis
and lower levels of testosterone in situ (T. Goluza et al.). The
fertilization potential of spermatozoa depends on appropriate
and time-dependent process of hyperactivation, chemotaxis,
capacitation, and the acrosome reaction, where calcium
(Ca2+) is extensively involved in almost every step. Modern
proteomic analyses have identified several sperm proteins,
and therefore these findings might provide further insight
into understanding the Ca2+ influx, protein functions, and
regulation of fertility (M. S. Rahman et al.).
At present there is still no generally accepted clini-
cal treatment to improve the semen quality in infertile
men, although some clinical trials showed that this may
be improved by oral administration of antioxidants (S.
Imamovic Kumalic and B. Pinter). Furthermore, a special
concern are also the paternal, sperm-borne mitochondria
(mt) that are selectively degraded inside the fertilized oocytes.
Assisted reproductive therapies (ART) such as intracytoplas-
mic sperm injection (ICSI) for male infertility treatment
include the injection of the entire sperm into oocytes includ-
ing mitochondria and mtDNA; therefore, sperm mitochon-
drial degradation mechanisms may play a crucial role with
implications to health, fitness and fertility, and development
and health of ART babies (W.-H. Song et al.).
Array comparative genomic hybridization (aCGH) for
comprehensive screening of all chromosomes is becoming a
new tool for selection of euploid embryos to be transferred
in the in vitro fertilization program (L. Rodrigo et al.)
and can improve the clinical outcome—pregnancy rate—
in women with repeated implantation failure (E. Greco et
al.). Yet, some caution is needed, because embryo biopsy
is an invasive procedure, and less invasive procedures to
distinct normal and abnormal embryos need to be devel-
oped (T. Vladimirova Milachich). Not only embryo but
also the endometrium plays an important role in successful
implantation. One of the first studies confirmed that the
infusion of granulocyte colony-stimulating factor (G-CSF)
leads to the improvement in endometrium thickness and
the chance to achieve pregnancy in women with treatment-
resistant thin endometrium (M. Kunicki et al.). In a clinical
study, tissue Doppler imaging (TDI) based elastography was
used for assessment of cervical stiffness during all three
trimesters of pregnancy and a correlation with gestational
age, cervical length, and parity was found (A. Fruscalzo
et al.). Fetal middle cerebral artery (MCA) circulation was
followed after defined prenatal acoustical stimulation (PAS),
correlating the role of cilia in hearing and memory in fetus
to signal transduction (i.e., optical-acoustical properties).
The authors suggest that fetuses are getting used to sound,
developing a kind ofmemory patterns, considering acoustical
and electromagnetic waves (S. Jankovic-Raznatovic et al.).
Further, BACs-on-beads technology represents a new and
reliable test for rapid detection of fetal aneuploidies and
microdeletions in prenatal diagnostics (S. Garc´ıa-Herrero et
al.). Quantitative proteomics analysis revealed the altered
protein expression in the placental villous tissue of early
pregnancy loss using isobaric tandem mass tags and may
represent a new diagnostic tool in the future (X. Ni et al.).
Besides in vitro fertilization itself, cryopreservation of
embryos, gametes, and reproductive tissues represents an
extremely important part of assisted conception to pre-
serve the potential of life and fertility, as reviewed by J.
Konc et al. Advanced experimental data were provided on
new approaches to human ovarian tissue cryopreservation
in young cancer patients, showing vitrification with good
preservation of stromal cells without apoptosis in human
ovarian tissue (R. Fabbri et al.) and an effective in vitro
perfusion of ovine intact ovaries with vascular pedicle by
freezing medium, important for development of whole ovary
cryopreservation in humans (V. Isachenko et al.). An option
in cancer patients is also to cryopreserve the oocytes, if
ovarian stimulation is safe and possible, but this is not an
easy task and was thoroughly reviewed in bovine oocytes (I.-
S. Hwang and S. Hochi). The data also show that superoxide
dismutase (SOD) represents a good predicting factor for
boar semen characteristics after short-term cryostorage (M.
Zakosek Pipan et al.) andmay be applied in humanmedicine.
Each birth of a baby after in vitro fertilization still
represents a great effort and a “miracle.” During the last
years, several studies have shown that babies after assisted
conception are healthy and do not differ from other babies.
Nevertheless, permanent concern is needed for both mother
and baby to be safe and healthy. In a clinical study, singleton
pregnancy and neonate outcomes after in vitro fertilization
with fresh or frozen-thawed embryo transfer were followed
in a large group of women (S. Korosec et al.).
The perspectives and challenges of pluripotent and
induced pluripotent stem cells as new agents for treatment
of infertility are discussed by V. Volarevic et al. Moreover,
stem cells from follicular aspirates in infertile women were
successfully cultured in vitro. They expressed several genes
related to mesenchymal stem cells and were successfully
differentiated into cells of all three germ layers (E. Dzafic et
al.). These cells may be interesting for both the reproductive
(e.g., regeneration of ovaries) and regenerative medicine.
Also spermatogonial stem cells were further researched by
generating gene expression profiles for human spermatogo-
nia both after short- and long-term culture (S. Conrad et al.).
In this special issue, it is also reported that full reim-
bursement of in vitro fertilization with repeated attempts can
provide a notable success considering cumulative delivery
rate and should thus be proposed to public health systems (U.
Vrtacnik et al.). All great efforts summarized in this special
issue not only bring several scientific and clinical answers but
also open some new questions, which are an important task
and an exciting challenge for the future.
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